Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gee

Showing results (121-130 of 419) with videos related to

Pageof 42
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2011
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignanciesJakob R Passweg, Mei-Jie Zhang, Vanderson Rocha, et al.
Blood|October 31, 2008
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patientsChrystal U Louis, Karin Straathof, Catherine M Bollard, et al.
Blood|October 24, 2002
Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infectionBarbara Savoldo, M Helen Huls, Zhensheng Liu, et al.
Transfusion|January 28, 2009
Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapiesWilliam Reed, Stephen J Noga, Adrian P Gee, et al.
Science Translational Medicine|June 27, 2014
Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCTAnastasia Papadopoulou, Ulrike Gerdemann, Usha L Katari, et al.
Blood|September 29, 2018
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantationLauren P McLaughlin, Rayne Rouce, Stephen Gottschalk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outcomeK T Godder, L J Hazlett, S H Abhyankar, et al.
The Journal of Clinical Investigation|May 5, 2011
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patientsBarbara Savoldo, Carlos Almeida Ramos, Enli Liu, et al.
Nature Medicine|November 4, 2008
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaMartin A Pule, Barbara Savoldo, G Doug Myers, et al.
Blood|July 5, 2007
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transferCatherine M Bollard, Stephen Gottschalk, Ann M Leen, et al.
Pageof 42

Showing results (121-130 of 419) with videos related to

Sort By:
Pageof 42
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2011
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignanciesJakob R Passweg, Mei-Jie Zhang, Vanderson Rocha, et al.
Blood|October 31, 2008
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patientsChrystal U Louis, Karin Straathof, Catherine M Bollard, et al.
Blood|October 24, 2002
Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infectionBarbara Savoldo, M Helen Huls, Zhensheng Liu, et al.
Transfusion|January 28, 2009
Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapiesWilliam Reed, Stephen J Noga, Adrian P Gee, et al.
Science Translational Medicine|June 27, 2014
Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCTAnastasia Papadopoulou, Ulrike Gerdemann, Usha L Katari, et al.
Blood|September 29, 2018
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantationLauren P McLaughlin, Rayne Rouce, Stephen Gottschalk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outcomeK T Godder, L J Hazlett, S H Abhyankar, et al.
The Journal of Clinical Investigation|May 5, 2011
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patientsBarbara Savoldo, Carlos Almeida Ramos, Enli Liu, et al.
Nature Medicine|November 4, 2008
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaMartin A Pule, Barbara Savoldo, G Doug Myers, et al.
Blood|July 5, 2007
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transferCatherine M Bollard, Stephen Gottschalk, Ann M Leen, et al.
Pageof 42